


Flat-fee plan pricing makes it easier to treat retirement benefits as part of a long-term business strategy rather than a variable expense that might change unexpectedly.

Aritificial intelligence is opening new possibilities for retirement plans, but employers remain cautious about risk while working to improve participant outcomes and readiness.
Metabolism-management drugs and hormone therapy are growing in popularity, but women need expert clinical oversight in conjunction with medication access.
The CEO of workforce management and HR technology company Würk has a unique take on the return to the office.
A wide range of employers are expressing a greater desire to measure risk, achieve more predictable retirement benefit costs, and retain top talent.